Malte Roerden

Otfried Müller Str. 10
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL.

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL.

Journal: Blood advances

Published: July 15, 2025

Cancer immune evasion, immunoediting and intratumour heterogeneity.

Cancer immune evasion, immunoediting and intratumour heterogeneity.

Journal: Nature reviews. Immunology

Published: November 05, 2024

Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression.

Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression.

Journal: Journal for immunotherapy of cancer

Published: October 10, 2024

Validation and quantification of peptide antigens presented on MHCs using SureQuant.

Validation and quantification of peptide antigens presented on MHCs using SureQuant.

Journal: Nature protocols

Published: December 20, 2023

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Journal: Blood cancer discovery

Published: February 03, 2023

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression.

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression.

Journal: eLife

Published: November 30, 2022

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts.

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts.

Journal: Nature communications

Published: October 04, 2022

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity.

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity.

Journal: iScience

Published: June 27, 2022

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.

Journal: Nature

Published: August 17, 2021

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.

Journal: Frontiers in immunology

Published: May 06, 2021

Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy.

Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy.

Journal: Cancers

Published: March 29, 2021

Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome.

Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome.

Journal: Leukemia & lymphoma

Published: March 02, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026